Literature DB >> 11939393

Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients.

S K P Lau1, P C Y Woo, K W Leung, K Y Yuen.   

Abstract

Clinical and microbiological data were collected prospectively from 704 patients who underwent bone marrow transplantation (BMT) during an 11-year period (1991-2001), and the first two cases of Campylobacter infection occurring in BMT recipients in the pre-engraftment period were identified. The two cases occurred on days 2 and 3 post-BMT, respectively. Both patients had Campylobacter jejuni enteritis, and one case was complicated by bacteraemia. In both cases the presenting symptoms were indistinguishable from hospital-acquired pre-engraftment diarrhoea, which is commonly caused by Clostridium difficile. Both of the Campylobacter jejuni isolates were resistant to cotrimoxazole and ciprofloxacin. Both patients responded to intravenous meropenem and subsequently had uneventful marrow engraftment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939393     DOI: 10.1007/s10096-001-0673-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

1.  Pilot study for the development of a new campylobacter selective medium at 37 degrees C using aztreonam.

Authors:  G D Thomas
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 2.  A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature.

Authors:  A Monselise; D Blickstein; I Ostfeld; R Segal; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-24       Impact factor: 3.267

3.  In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.

Authors:  Rea Krausse; Uwe Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.

Authors:  Mirva Lehtopolku; Ulla-Maija Nakari; Pirkko Kotilainen; Pentti Huovinen; Anja Siitonen; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

5.  [Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-04       Impact factor: 1.513

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.